Organization | Medical University of Graz

Medical University of Graz Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Graz Austria (1585)

Organization Overview

First Clinical Trial

2004

NCT00407342

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Graz, Austria. helmar.bornemann@medunigraz.at | Department of Internal Medicine, Division of Hematology, Medical University of Graz | Department of Internal Medicine, Medical University of Graz | Department of OB/GYN of the Medical University of Graz | Dept. of Anesthesia and Intensive Care Medicine, Medical University of Graz | Dept of Internal Medicine, Medical University of Graz | Dept. of Internal Medicine, Medical University of Graz, Austria | Division of Endocrinology and Metabolism, Department of Internal Medicine Medical University of Graz | Division of Neonatology, Medical University of Graz | Graz Medical University | Green Beat and Medical University of Graz | Hansa Sanatorium GmbH, Graz | Harald Dobnig, MD | Head and Chair of Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University, Graz, Austria | Medical University Graz | Medical University Graz, Austria | Medical University, Graz, Austria | Medical University Graz, Internal Medicine, Endocrinology and Nuclear Medicine | Medical University of Graz | Medical University of Graz (Austria) | Medical University of Graz, Austria | Medical University of Graz, Departement for General Surgery | Medical University of Graz, Department of Internal Medicine | Medical University of Graz, Department of Internal Medicine, Division of Clinical Oncology | Medical University of Graz Department of Pediatrics and Adolescent Medicine, Graz, Austria | Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine | Medical University of Graz, Dept. of Internal Medicine, Auenbruggerpl. 15, 8036 Graz, Austria | Medical University of Graz, Dept. of Internal Medicine, Div. of Endocrinology and Metabolism, Auenbruggerpl. 15, 8036 Graz, Austria | Medical University of Graz, Division of Endocrinology and Diabetology | Medical University of Graz, Graz, Austria | Medical University of Graz, Graz, Styria, Austria | Medical University of Graz, Internal Medicine, Endocrinology and Metabolism | MEDIZINISCHE UNIVERSITAT GRAZ | Medizinische Universität Graz | Med. U Graz | Med Uni Graz | MUG | nandu.goswami@medunigraz.at | Research Unit for Photodermatology, Department of Dermatology, Medical University Graz | University Hospital Graz | University of Graz | Univ. Klinikum Graz | Vanessa Stadlbauer-Koellner, MD

Active Ingredients

Drugs in Phase 4 Trials (35)

abatacept (orencia) (1 trial)

adalimumab (humira) (1 trial)

albumin (Human) (Plasbumin) (1 trial)

amoxicillin (2 trials)

apremilast (otezla) (1 trial)

certolizumab pegol (cimzia) (1 trial)

clonidine (catapres) (1 trial)

dapagliflozin (farxiga) (1 trial)

dinoprostone (prostin e2) (1 trial)

echinaforce (1 trial)

etanercept (enbrel) (1 trial)

ezetimibe (zetia) (1 trial)

fentanyl (Innovar) (2 trials)

fluvastatin (lescol) (1 trial)

glucose (1 trial)

golimumab (simponi) (1 trial)

imiquimod (aldara) (4 trials)

infliximab (remicade) (3 trials)

insulin glargine (toujeo) (2 trials)

insulin human (humulin) (6 trials)

insulin lispro (humalog) (6 trials)

lactulose (cephulac) (1 trial)

lidocaine (xylocaine) (4 trials)

linagliptin (tradjenta) (1 trial)

liraglutide (victoza) (3 trials)

losartan (cozaar) (1 trial)

metformin (glucophage) (1 trial)

phenylephrine (Prefrin) (1 trial)

prilocaine (citanest) (4 trials)

remifentanil (ultiva) (1 trial)

sucrosomial iron (1 trial)

telmisartan (micardis) (1 trial)

tocilizumab (actemra) (1 trial)

tropicamide (mydriacyl) (1 trial)

vitamin d3 (14 trials)

Drugs in Phase 3 Trials (29)

apixaban (eliquis) (1 trial)

aramchol (1 trial)

atorvastatin (lipitor) (1 trial)

bevacizumab (avastin) (1 trial)

cetuximab (erbitux) (1 trial)

cisplatin (platinol) (1 trial)

dabigatran (pradaxa) (1 trial)

dronabinol (marinol) (1 trial)

edoxaban (savaysa) (1 trial)

empagliflozin (jardiance) (1 trial)

enoxaparin (lovenox) (1 trial)

ertugliflozin (Steglatro) (1 trial)

ferric carboxymaltose (Injectafer) (1 trial)

human fecal microbiota (1 trial)

insulin detemir (Levemir) (2 trials)

ketamine (ketalar) (1 trial)

methoxsalen (1 trial)

miglitol (glyset) (1 trial)

oxygen (2 trials)

physostigmine (1 trial)

pregabalin (lyrica) (1 trial)

progesterone (progestasert) (1 trial)

protamine insulin (1 trial)

ranibizumab (lucentis) (1 trial)

rivaroxaban (xarelto) (1 trial)

serlopitant (1 trial)

spermidine (1 trial)

testosterone (delatestryl) (1 trial)

Drugs in Phase 2 Trials (23)

aadvac1 (1 trial)

acetaminophen (tylenol) (1 trial)

ambrisentan (letairis) (1 trial)

autologous platelets (1 trial)

benzbromarone (1 trial)

bnt162b2 (1 trial)

doxorubicin (Doxil) (1 trial)

ethanol (1 trial)

f16il2 (1 trial)

lactobacillus delbrueckii (2 trials)

ladostigil hemitartrate (1 trial)

lapatinib (tykerb) (1 trial)

moli1901 (1 trial)

mv-chik (1 trial)

paclitaxel (taxol) (2 trials)

pazopanib (votrient) (1 trial)

priorix (1 trial)

saxagliptin (onglyza) (1 trial)

sodium chloride (2 trials)

sodium selenium oxide (1 trial)

vaxzevria (1 trial)

verapamil (calan) (1 trial)

vorinostat (zolinza) (1 trial)

Drugs in Other Trials (35)

aciclovir (zovirax) (1 trial)

alefacept (Amevive) (1 trial)

bacillus coagulans (1 trial)

bacillus subtilis (1 trial)

b complex vitamin (1 trial)

bicarbonate (1 trial)

bifidobacterium bifidum (4 trials)

bifidobacterium lactis (4 trials)

biotin (1 trial)

bosentan (tracleer) (1 trial)

calcipotriene (dovonex) (1 trial)

cisatracurium (nimbex) (1 trial)

cranberry (1 trial)

crystalloid (1 trial)

diclofenac (voltaren) (1 trial)

enterococcus faecium w54 (2 trials)

insulin aspart (novolog) (1 trial)

ivabradine (corlanor) (1 trial)

keyhole limpet hemocyanin (1 trial)

Lactobacillus acidophilus (3 trials)

lactobacillus casei (2 trials)

lactobacillus paracasei (3 trials)

lactobacillus plantarum (3 trials)

lactobacillus rhamnosus (3 trials)

lactobacillus salivarius (4 trials)

lactococcus lactis (2 trials)

macrogol (1 trial)

multivitamins (1 trial)

nevulose (1 trial)

palmitoylethanolamide (1 trial)

probiotic (1 trial)

propionibacterium freudenreichii (1 trial)

propofol (diprivan) (1 trial)

sodium bicarbonate (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alzheimer Disease (Phase 2)

Amnesia (Phase 2)

Anemia, Iron-Deficiency (Phase 4)

Arthritis (Phase 4)

Arthritis, Psoriatic (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Atrial Fibrillation (Phase 3)

Avitaminosis (Phase 2)

Bacterial Infections (Phase 4)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 3)

Carcinoma in Situ (Phase 3)

Carcinoma, Merkel Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Carcinosarcoma (Phase 2)

Cerebral Hemorrhage (Phase 3)

Cervical Intraepithelial Neoplasia (Phase 3)

Chikungunya Fever (Phase 2)

Cholangitis (Phase 4)

Cognitive Dysfunction (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Critical Illness (Phase 3)

Cystic Fibrosis (Phase 2)

Dementia (Phase 2)

Dermatitis, Contact (Phase 3)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Endometrial Stromal Tumors (Phase 2)

Exanthema (Phase 3)

Familial Primary Pulmonary Hypertension (Phase 2)

Fatty Liver (Phase 3)

Fibrosis (Phase 3)

Fractures, Closed (Phase 4)

Glucose Intolerance (Phase 4)

Graft vs Host Disease (Phase 3)

Head and Neck Neoplasms (Phase 3)

Heart Arrest (Phase 2)

Heart Failure (Phase 3)

Hemangiosarcoma (Phase 2)

Hemorrhage (Phase 3)

Hip Fractures (Phase 3)

Hutchinson's Melanotic Freckle (Phase 3)

Hypercholesterolemia (Phase 4)

Hyperglycemia (Phase 4)

Hypertension (Phase 4)

Hypogonadism (Phase 4)

Infarction (Phase 3)

Infections (Phase 4)

Insulin Resistance (Phase 4)

Joint Diseases (Phase 4)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 2)

Leiomyosarcoma (Phase 2)

Lentigo (Phase 3)

Liver Cirrhosis (Phase 3)

Liver Cirrhosis, Biliary (Phase 3)

Liver Diseases (Phase 4)

Lupus Erythematosus, Systemic (Phase 3)

Lupus Nephritis (Phase 3)

Macular Degeneration (Phase 3)

Memory Disorders (Phase 2)

Metabolic Syndrome (Phase 4)

Mixed Tumor, Mullerian (Phase 2)

Mycoses (Phase 3)

Mycosis Fungoides (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 4)

Nausea (Phase 3)

Neoplasms (Phase 3)

Nephritis (Phase 3)

Neurodermatitis (Phase 3)

Obesity (Phase 4)

Pain, Postoperative (Phase 3)

Pancreatic Neoplasms (Phase 3)

Pneumonia (Phase 4)

Polycystic Ovary Syndrome (Phase 4)

Pre-Eclampsia (Phase 3)

Prurigo (Phase 3)

Pruritus (Phase 3)

Recurrence (Phase 3)

Rickets (Phase 2)

Sarcoma (Phase 2)

Spinal Cord Injuries (Phase 2)

Syndrome (Phase 4)

Ulcer (Phase 3)

Urinary Tract Infections (Phase 4)

Virus Diseases (Phase 2)

Vitamin D Deficiency (Phase 4)

Vomiting (Phase 3)

Weight Gain (Phase 3)

Wounds and Injuries (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 133
# of Trial APIs: 122